Bristol Myers Squibb ASPIREs For Access In LMICs
In Vivo spoke with Adam Lenkowsky, executive vice-president, and chief commercialization officer at Bristol Myers Squibb
BMS has launched a new cancer drug access program for low-to-middle income countries, focusing on addressing health inequities and widening accessibility.
